Evidence map›Paper›PMID 35660104›Full record

ArticleBiophysical journal2022

Understanding the molecular mechanism of endothelin ET

Lingyun Wang, Lingling Wang, Feng Yan

Open access · greenAbstract read
In one paragraph

Article in Biophysical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Lingyun WangDivision of Nephrology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: lywang@uab.edu.
Lingling WangDepartment of Biostatistics, The University of Alabama at Birmingham, Birmingham, Alabama.
Feng YanSchool of Chemistry, Tiangong University, Tianjin, Republic of China; State Key Laboratory of Separation Membranes and Membrane Processes, Tiangong University, Tianjin, Republic of China. Electronic address: yanfeng@tiangong.edu.cn.
University of Alabama at Birmingham · USTiangong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelin-1 and -3 (ET1 and ET3) are potent vasoconstricting isopeptides that are involved in the pathophysiology of various diseases, such as cardiovascular and renal diseases. The two ETs exert their effects by binding to two G-protein-coupled receptors (GPCRs), the endothelin ET

Indexed as

Endothelin-1EndothelinsReceptor, Endothelin AEndothelin-1EndothelinsReceptor, Endothelin A

Identifiers

PMID35660104
PMCPMC9300638
OpenAlexW4281671310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.